Refresh

Ankur Drugs & Pharma Ltd. - Research Center

531683 ANKURDRUGS Group (T) BSE data
Back to Company

Results

Statement

More

Profit & Loss Account
(Rs crore)
Mar ' 12 Mar ' 11 Mar ' 10 Mar ' 09 Mar ' 08
Income

Operating income

151.49 824.85 1,067.66 965.75 673.73
Expenses

Material consumed

115.35 619.59 800.55 743.18 541.42

Manufacturing expenses

3.35 6.28 22.36 26.86 12.42

Personnel expenses

18.80 20.44 17.94 5.19 8.63

Selling expenses

- - 2.41 2.26 0.63

Adminstrative expenses

41.90 44.64 15.20 8.47 3.29

Expenses capitalised

- - - - -

Cost of sales

179.39 690.95 858.47 785.96 566.39

Operating profit

-27.90 133.90 209.19 179.79 107.33

Other recurring income

0.19 0.93 1.60 2.48 1.26

Adjusted PBDIT

-27.72 134.83 210.79 182.27 108.60

Financial expenses

58.36 120.80 80.75 75.04 24.93

Depreciation

66.03 60.80 26.64 20.67 8.40

Other write offs

- - 0.13 0.12 0.26

Adjusted PBT

-152.11 -46.77 103.27 86.44 75.00

Tax charges

19.02 22.04 29.07 21.80 11.51

Adjusted PAT

-171.13 -68.81 74.20 64.64 63.49

Non recurring items

-136.37 - 16.73 -27.52 0.01

Other non cash adjustments

- - -4.76 0.01 -0.75

Reported net profit

-307.49 -68.81 86.18 37.13 62.75

Earnigs before appropriation

-243.68 63.81 187.75 126.58 104.35

Equity dividend

- - 4.35 4.28 4.19

Preference dividend

- - - - -

Dividend tax

- - 0.78 0.73 0.71

Retained earnings

-243.68 63.81 182.62 121.57 99.45
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com